Pharmacological Complexities of Herbal Medicinal Extracts: A Review of Bioavailability, Interactions, and Standardization
Top Cited Papers
- 1 May 2026
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Drug Metabolism
- Vol. 27 (3) , 157-173
Abstract
Herbal medicines have gained remarkable popularity due to their natural origins and potential medicinal value. Nevertheless, they are chemically complex and pose signifi-cant pharmacological challenges. This review focuses on the key aspects influencing their clinical use: their variable bioavailability, complex pharmacokinetics (ADME), and potential for interactions. A primary concern is herb-drug interactions, with special emphasis on the modulation of drug-metabolizing enzymes by specific phytoconstituents, which can alter drug concentrations to an extent that may be life-threatening, causing either increased toxicity or therapeutic failure. The pharmacological profile is further complicated by the complex effects of constituents, such as synergistic or antagonistic actions, which make predicting therapeutic response and safety difficult. A critical challenge in this field is the frequent dis-connect between in vitro findings and in vivo outcomes, underscoring the importance of phar-macokinetic data, particularly bioavailability, for accurate clinical risk assessment. Safety is a paramount concern, as it is often compromised by inconsistent standardization and quality control, leading to batch-to-batch variability, potential adulteration, and contamination. The absence of stringent regulation impairs therapeutic consistency and introduces health risks. To address these issues, advanced approaches are being employed to improve bioavailability, including novel drug delivery systems that enhance solubility and stability. This review em-phasizes that a rigorous, phytoconstituent-centric approach is essential for navigating the complexities of herbal medicine. By addressing challenges in pharmacokinetics, interactions, safety, standardization, and bioavailability through rigorous scientific investigation and em-bracing future perspectives, such as in silico modeling and improved regulatory frameworks, the quality, safety, and effectiveness of herbal treatments can be ensured, supporting their responsible integration into modern, evidence-based medical systems.Keywords
This publication has 91 references indexed in Scilit:
- In silico identification of phytoconstituents from Capparis sepiaria as interleukin-1 inhibitors for rheumatoid arthritis: molecular docking, ADMET profiling, and molecular dynamics simulationIn Silico Pharmacology, 2025
- Kratom withdrawal: Discussions and conclusions of a scientific expert forumDrug and Alcohol Dependence Reports, 2023
- Differential annotation of converted metabolites (DAC-Met): Exploration of Maoto (Ma-huang-tang)-derived metabolites in plasma using high-resolution mass spectrometryMetabolomics, 2020
- Accidental poisoning with Aconitum: Case report and review of the literatureClinical Case Reports, 2020
- Review of herbal medications with the potential to cause bleeding: dental implications, and risk prediction and prevention avenuesEPMA Journal, 2019
- In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in ratsChemico-Biological Interactions, 2017
- Selective reduction in the expression of UGTs and SULTs, a novel mechanism by which piperine enhances the bioavailability of curcumin in ratBiopharmaceutics & Drug Disposition, 2017
- Co-administration of St. John's wort and hormonal contraceptives: a systematic reviewContraception, 2016
- Chinese herbal medicine for menopausal symptomsCochrane Database of Systematic Reviews, 2016
- PHARMACOKINETICS AND PHARMACODYNAMICS OF CURCUMIN2007